Mothaffar Rimawi

Mothaffar Rimawi

Baylor College of Medicine - Houston / United States
Others
AD Scientific Index ID: 854464
person_outline Mothaffar Rimawi's MOST POPULAR ARTICLES
1-) TBCRC 001: randomized phase II study of cetuximab in combination with carboplatin in stage IV triple-negative breast cancer Journal of clinical oncology 30 (21), 2615-2623, 2012
2-) Tamoxifen resistance in breast tumors is driven by growth factor receptor signaling with repression of classic estrogen receptor genomic function Cancer research 68 (3), 826-833, 2008
3-) A renewable tissue resource of phenotypically stable, biologically and ethnically diverse, patient-derived human breast cancer xenograft models Cancer research 73 (15), 4885-4897, 2013
4-) TBCRC 022: a phase II trial of neratinib and capecitabine for patients with human epidermal growth factor receptor 2–positive breast cancer and brain metastases Journal of Clinical Oncology 37 (13), 1081-1089, 2019
5-) Targeting HER2 for the treatment of breast cancer Annual review of medicine 66 (1), 111-128, 2015